← Open Payments lookup

MUSTAFA SIDALI: Open Payments

NPI 1811982762 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,740 in 84 payments from 17 companies in 2025. Trend: 2023 $137 · 2024 $1,818 · 2025 $1,740

Food & beverage: $1,655Education: $85
CompanyPaymentsAmount
Novo Nordisk Inc16$331
AstraZeneca Pharmaceuticals LP15$314
GlaxoSmithKline, LLC.6$201
Mannkind Corporation11$172
Lilly USA, LLC11$164
Madrigal Pharmaceuticals1$148
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$69
Kowa Pharmaceuticals America, Inc.4$57
Exact Sciences Corporation2$50
ABBVIE INC.3$48

Products named: Ozempic, FARXIGA, AFREZZA, REZDIFFRA, MOUNJARO, AREXVY, JARDIANCE, BREZTRI.

Industry payments across NJ — which companies pay providers there.